https://www.cdpr.ca.gov/stakeholder-notice/preliminary-reports-relative-to-reevaluation-of-paraquat-informal-public-comment-period/
Preliminary Reports Relative to Reevaluation of Paraquat: Informal Public Comment Period -...
preliminary reportsrelative topublic commentreevaluation
https://markets.businessinsider.com/news/stocks/orthofix-reports-preliminary-q1-revenue-196-7m-consensus-193-28m-1036008377
Orthofix reports preliminary Q1 revenue $196.7M, consensus $193.28M | Markets Insider
These preliminary, unaudited net sales results for the first quarter ended March 31, 2026 are based on current expectations and are subject to q...
https://markets.businessinsider.com/news/stocks/eqs-afr-deutsche-lufthansa-ag-preliminary-announcement-of-the-publication-of-quarterly-reports-and-quarterly-interim-statements-1035053063
EQS-AFR: Deutsche Lufthansa AG: Preliminary announcement of the publication of quarterly reports...
EQS Preliminary announcement financial reports: Deutsche Lufthansa AG / Preliminary announcement on the disclosure of financial s...
deutsche lufthansa agpreliminary announcement
https://safety.army.mil/MEDIA/Risk-Management-Magazine/PgrID/7428/PageID/65/PID/7428/evl/0/CategoryID/197/CategoryName/Preliminary-Loss-Reports
Preliminary Loss Reports - USACRC
preliminarylossreports
https://preview.weather.gov/oun/stormdata
Preliminary Monthly Storm Data Reports for Western, Central and Southern Oklahoma and Western North...
data reports
https://www.weather.gov/lub/events-2014-20140623-storms-lsr
NWS Lubbock, TX, Preliminary Storm Reports for June 23, 2014
lubbock txstorm reportsnwspreliminaryjune
https://safety.army.mil/MEDIA/Risk-Management-Magazine/PgrID/7428/PageID/22/PID/7428/evl/0/CategoryID/197/CategoryName/Preliminary-Loss-Reports
Preliminary Loss Reports - USACRC
preliminarylossreports
https://safety.army.mil/MEDIA/Risk-Management-Magazine/PgrID/7428/PageID/52/PID/7428/evl/0/CategoryID/197/CategoryName/Preliminary-Loss-Reports
Preliminary Loss Reports - USACRC
preliminarylossreports
https://markets.businessinsider.com/news/stocks/biostem-technologies-reports-record-preliminary-fourth-quarter-net-revenue-of-102-9-million-and-preliminary-full-year-2024-revenue-of-301-8-million-1034581841
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and...
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024Achi...
https://www.aa.com.tr/en/americas/lawyers-for-suspect-in-charlie-kirk-killing-seek-to-postpone-preliminary-hearing-reports/3885912
Lawyers for suspect in Charlie Kirk killing seek to postpone preliminary hearing: Reports
Mar 31, 2026 - In motion, Tyler Robinson's attorneys say the Bureau of Alcohol, Tobacco, Firearms and Explosives has unable to link a bullet fragment recovered during the...
https://betterworld.mit.edu/preliminary-reports-examine-options-for-mit-schwarzman-college-of-computing/preliminary-reports-examine-options-schwarzman-college-of-computing-01/
preliminary-reports-examine-options-schwarzman-college-of-computing-01 | MIT for a Better World
Jan 23, 2020 - MIT campus. Image: Jake Belcher
https://markets.businessinsider.com/news/stocks/eqs-afr-pne-ag-preliminary-announcement-of-the-publication-of-financial-reports-according-to-articles-114-115-117-of-the-wphg-the-german-securities-act-1034917279
EQS-AFR: PNE AG: Preliminary announcement of the publication of financial reports according to...
EQS Preliminary announcement financial reports: PNE AG / Preliminary announcement on the disclosure of financial statements ...
https://www.businesswire.com/news/home/20220607005523/en/AlloVir-Reports-Blinded-Preliminary-Phase-2-Data-Supporting-the-Ongoing-Study-of-Posoleucel-a-Multi-Virus-Specific-T-Cell-Therapy-for-the-Treatment-of-BK-Viremia-in-Kidney-Transplant-Recipients
AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a...
AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced preliminary, blinded data from an ongoing Phase ...
https://www.businesswire.com/news/home/20230426006024/en/Sangamo-Therapeutics-Announces-Strategic-Update-and-Reports-Preliminary-First-Quarter-2023-Financial-Results
Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023...
SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS PRELIMINARY FIRST QUARTER 2023 FINANCIAL RESULTS
first quartersangamotherapeuticsannouncesstrategic
https://www.businesswire.com/news/home/20260106391108/en/Brenus-Pharma-Reports-Favorable-Tolerability-and-Clinical-Signals-in-Early-Preliminary-Results-of-First-In-Human-Study-for-STC-1010-in-Unresectable-Metastatic-Stage-Colorectal-Cancer-MSS-CRC-Patients?_gl=1*1c5s3e1*_gcl_au*ODE5NzcxMDcyLjE3Njc3MTYyMjA.*_ga*MTAxODA2MDk5MS4xNzQ5MTk2MjE4*_ga_ZQWF70T3FK*czE3Njc3MzUyODMkbzUxJGcxJHQxNzY3NzM1Mjk2JGo0NyRsMCRoMA..
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of...
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the f...